Colinz

Date: 30/05120t6

To,

Bombay Stock Exchange Limited

Ph i roze Jeejeeboy Towers,
Dalal Street,
Mumbai - 400001

Dear Sir,
Sub: Outcome of the Board Meeting
BSE

Code:531210

The Meeting of Board of Directors was held on Monday, 30th May, 2016 at L2.30
P.M. at the registered office of the Company at A-101, Pratik lndustrial Estate, Next
to Fortis Hospital, Mulund Goregaon Link Road ,Mumbai -,400078 has approved the
Audited Financial Results for the quarter and year ended on 31't March, 201,6.
This is for your information and record.

Thanking you,
Yours faithfully,
FOR COLINZ LABORATORIES LTD

Colinz Laboratories Limited

llr.\

a/llnnlrLll

Oa(DT nn,{ 1 1,}O

Colinz
A-10{, pratik ,"0.

=",",","*?li}=-:t?3"Xil3}j1:*l[it"i?;(ClN NO : L24200MH1986PLC041128)

Road, Mumbai- 400 078

AUDITED FINANCIAL RESULTS FoR THE YEAR ENDED 31sr MARCH, 2016
(Rupees in'000')
Un -audited

Particulars

S. No.

Quarter ended
31.03.2016

PART.
1

l1a;
I

31 .03.20'15

31.03.2016

31.03.2015

82,112
3,255
78,857
78.857

Gross Sales
Less: Excise Duty
Net Sales
(b) Other Operating lncome

19,s46
1,178
18,368

19,352
525

17,868

18,827

17,060

83,989
3,036
80,953

Total lncome from Operation

Expenditure

18,368

18.827

17,060

80,953

6,401

3,601

4,1 56

4,789

2,363

8,614
(6,077)

17,528
13,345

(a)
(b)

(c)
(d)
(e)

(0
J

.12.2015

lncome from Operation

II

31

Audited
Year Ended
Year Ended

Consumption of Materials
Purchase of Goods Traded
(lncrease)/Decrease in stock in trade
Staff Cost
Depreciation
Other Expenditure

(3,636)

6,622
71',l

3,15s
18,042
326
295

Total Expenditure
Profit /Loss from Operation Before Other lncome (1-2)
Other lncome /(Loss)

1,598

BOB

7,175
703
3,049

3,520

18,489

16,871

5,648

16,372

27,076
(9,795)

3,962

27,663
2,975

338

'189

28,623
2,919
12,985
79,261
1,692

221

318

980

1,103

2,606

,010

13,063

77,354
1,503

Profit /Loss before lnterest & Exceptional items (3+4)

621

AAO

507

2,672

lnterest

289

271

326

1,158

1,151

Profit /Loss after lnterest but before exceptional items (5-6)

332

288

181

1,514

1,455

Exceptional items
Profit /Loss before Tax (7-8)
Tax Expenses (Provision for

332

288
40

18'1

98

50

1,514
275
293

1,455

80

154
35,441

198

181

946

35,441

354,39

35,441

965
354,39

8,416

7,470

0.21

0.21

2,894,901
63.33%

2,894,901
63.33%

10

11

12
13
14

Taxation):

Current tax
Deffered tax

Net ProfiuLoss after Tax (9-10)

Paid up Equity Share Capital (Face Value 10t Per Share)
[Net of allotment money in arrears]
Reserves Excluding Revaluation Reserves
Earning per share (EPS) before extraordinary item (not Annualised)
Basic & Diluted

PART.II
1

A. PARTICULARS OFSHAREHOLDING
Public Shareholding

i)
ii)
2

267
223

Number of Shares
Percentage of shareholding

2,894,901
63.33%

2,894,901
63-33o/o

63.33%

1,676,099

1,676,099
36.67%

1,676,099
36.670/o

1,676,099
36.67%

1,676,099

36.670/o

100%

100o/o

100o/o

100%

100o/o

2,894,901

Promoters and promoter group Shareholding

a)

Pledged/Encumbered

i) Number of shares
ii) Percentage of shares (as a % of the total shareholding of
promoter and promoter group)
iii) Percentage of shares (as aolo of the total share capital of the
company)

b)

Non-encumbered
i) Number of Shares
ii) Percentage ofshares (as a% ofthe total shareholding

of promoter and promoter group)

iii) Percentage ofshares (as a o/o ofthe total share capital ofthe
company)
B. INVESTORS COMPLAINTS
Pending at Begining of the Quarter
Received During the Quarter

36.67o/o

3 Months ended 31.03.2016

NIL
1

Disposed of During the Quarier

Remaining at ihe end of the Quarter

t)t
C o Iin

Lab

o ratori e s

L im i

teOre)7-;;i;?

CIN NO- L242OOMH|986PLC041rr*[a', r*or* 'u

Colinz
As at 31.03.2016

(Rupees in'000')
As at 31.03.2015

(Audited)

(Audited)

STATEMENT OF ASSETS AND LIAB ILITIES

Particulars
EQUITY AND LIABILITIES

SHARE HOLDERS FUND

a)
b)

Share Capital

Reserves and Surplus

Sub-Total of Shareholders Fund

35,441
27,140

35,439
26,191

62,s81

61,630

15,962

23,298

4,492

4,198

68

43

20,522

27,539

5,69;

fi,67;

8,621

6,724

14,319

17,398

NON CURRENT LIABILITIES

2
a)

Long term borrowing

b)

Deffered tax liability( net)

c)
d)

Other long term liability

Long term Provision

Sub-Total of Non Current Liabilities

3

a)
b)
c)

d)

CURRENT LIABILITIES
Short term borrowing
Trade payable
Other current liabilities
Short term provision

Sub-Total of Current Liabilities

Total ( 1+2+3)

a)
b)
c)
d)

ASSETS
NON CURRENT ASSETS
Fixed Assets
Non current investments
Long term loans and advances
Other Non current assets

lul
lnl
lc)
lOl

CURRENT ASSETS
lnventories
Trade receivable
Cash and cash equlvalents
Short term loans and advances

B
1

28,810
2,859

Sub-Total of Non Gurrent Assets

2
I

97,422

12,993

44,662

47,603

22,',!85

943

26,554
13,529
17,753
1,128

52,760

58,964

97,422

106,567

16,165

of

Current Assets
Total ( 1+2 )

06,567

3't,601
2,859
13,143-

13,467

Sub-Total

NOTES:-

l.Theabovefinancial resultshavebeentakenonrecordatameetingofBoardofDirectorsheldon

30.05.2016

2. The Company operates in single segment of manufacture of pharmaceutical formulations. Hence Accounting Standard on segment reporting is not applicable.
3) Previous period figures have been regrouped wherever required.

For and on behalf of the Board

COLINZ

LEEO#ORIES

LTD.

(cIN No , r-z+zclolfirssolrfno,,rn

MUMBAI.
30.05.2016
(DlN NO : 00825886)

Managing Director

Coli nz Laboratories Lim ited